(This post was last modified: 2013-09-29, 10:58 PM by anupam384.)
RE: Watchlist - Investor method
(2013-09-28, 08:49 PM)theory6453 Wrote:(2013-09-28, 03:44 AM)anupam384 Wrote: As far as the stocks that are in my watchlist or that I plan to get into soon are as follows:
znga - like it
halo - missed it
gern - missed it
gluu - will wait for it breakout
ctic - not sure if the base is in yet
pacb - like it
idra - love it
appy - will wait for it to breakout
onty - will wait for it breakout
gnvc - not sure if the base is in yet
Over to you experts !
Thanks anupam384! Of your picks, I think I also like IDRA the best (especially since pacb had HUGE move this week and would qualify as 'missed it' for me... hope you got in).
IDRA doubled in value since breakout and is now in a significant 30%-40% pullback. The majority of technicals look good to me to move higher and Health Care sector and Biotech sub-group are both in Stage 2. My one main concern would be that the volume has been higher on the pullback than it was on the actual breakout and we have talked about wanting to see the pullback on declining volume. Otherwise I would like to continue to see it pullback to $1.50 entry point before moving higher. It seems to have a lot of potential where I think ZNGA may still be a little premature.
Thanks for the heads up!
***Update - Here's an interesting article on IDRA
http://seekingalpha.com/article/1712362-...nd-q1-2014
You are welcome theroy6453. And thanks for pointing out the IRDA article. I know what you mean by the pullback on high volume, but that was because people were selling since IDRA did a secondary offering at 1.50. Also, I also found a press release where company insider bought 300,000 shares at 1.75 few weeks ago. Now that the secondary offering is out of the way, I believe this stock can run. Also, the stock found a lot of buyer the week after the pullback and week ended with an even higher volume.
But like you said, it can also drop to 1.50 again.
I think I am gonna go ahead and start a position in it and see where it goes from there. It it tanks I might add more.
Gook luck to you all.
(2013-09-29, 12:27 AM)isatrader Wrote:(2013-09-28, 03:44 AM)anupam384 Wrote: isatrader, yes I am still in RMTI up 110% and MAKO. Unfortunately I sold half my position just before it went up 100%. That is why I hate options, I thought I would move my money to a different stock which has not moved significantly yet.
Did you get a chance to take a position in RMTI like you mentioned in one of the earlier posts?
I wasn't overly keen on RMTI, as when you highlighted it, it was only in Stage 1A, but it obviously moved very quickly into Stage 2, and has done amazingly well for you. So I'm glad you are doing so well with it, but it was a bit too speculative for me personally.
(2013-09-28, 03:44 AM)anupam384 Wrote: As far as the stocks that are in my watchlist or that I plan to get into soon are as follows:
znga - like it
halo - missed it
gern - missed it
gluu - will wait for it breakout
ctic - not sure if the base is in yet
pacb - like it
idra - love it
appy - will wait for it to breakout
onty - will wait for it breakout
gnvc - not sure if the base is in yet
With the above list I'll try to just give my opinion of the Stages, relative performance, volume and resistance, as I don't want to influence you unduly.
ZNGA - closed the week above the Stage 1 range, and so is at the initial Stage 2A breakout point. Volume was 1.66 x the average, so a little bit short of the two times volume requirement, and relative performance closed above the zero line.
HALO - in Stage 2 for quite a few months, but broke above key resistance four weeks ago and is showing good relative performance and volume. Extended short term.
GERN - broke out into Stage 2A three weeks ago, and has moved sharply higher on increasing strong volume since, and cleared the 2012 high with this weeks close. Very extended short term.
GLUU - in Stage 1B, close to the Stage 2A breakout point. Volume has increased the last few weeks on the up weeks, and relative performance is close to crossing the zero line. Near term resistance from earlier in the year though if it does breakout.
CTIC - broke out in Stage 2A this week on over three times the average weekly volume, which has been increasing for the previous two weeks also. Relative performance also closed above the zero line, and it has some near term resistance just below the 2 level to get through.
PACB - made a sharp Stage 2 continuation move this week on 7 times the average weekly volume. Relative performance has been above the zero line for most of the year, and it closed the week above the 2012 high. Extended short term.
IDRA - broke out into Stage 2A in late July and moved sharply higher over the next two months on strong volume which built until the swing high at the end of August. It then pulled back on heavy volume and is currently around the 10 week MA. Relative performance has been strong, but it hasn't cleared the 2012 highs yet.
APPY - is in Stage 1 currently, under significant near term resistance from the late 2012 range. It had a heavy negative volume earlier in the summer, but volume has also picked up on it's recovery into Stage 1. Relative performance is still below the zero line currently, so I'd say it needs to close above the 3 area to move into Stage 2.
ONTY - I'd only put this one in early Stage 1. It's the least developed one so far imo and has significant near term resistance from earlier in the year. Relative performance is a long way below the zero line, but volume did pick up this week around 4 times the average.
GNVC - this one has catapulted into Stage 2A from it's lows, but is still under it's highs from earlier in the year. Relative performance has recovered and is just below the zero line, and volume has had a massive surge the last four weeks and was around 9 times the weekly average this week. Highly speculative one imo, as it has no real base for support if it drops back into Stage 1.
I hope that all helps
Cheers
Thanks isatrader. Your insights and analysis are always very appreciated. Do you personally like any of these. I am leaning towards IDRA